A director at Beiersdorf AG sold 2,705 shares at 124.000EUR and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
>Q3 sales organic growth at 5.2% - Q3 sales of € 2,375m at +2.4% with organic growth of 5.2% is below expectations both in reported basis and in organic terms. VA consensus was expecting 5.3% reported sales growth with 6.7% organic growth. We were more conservative with 4.3% reported sales growth and 6.3% organic growth. Indeed, Q3 organic growth in Q3 came in at 5.2% for the group vs VA css at 6.7% and ODDO BHF at 6.3%. Nevertheless, the company confirms the guidance...
>Q3 sales organic growth at 5.2% - Q3 sales of € 2,375m at +2.4% with organic growth of 5.2% is below expectations both in reported basis and in organic terms. VA consensus was expecting 5.3% reported sales growth with 6.7% organic growth. We were more conservative with 4.3% reported sales growth and 6.3% organic growth.Indeed, Q3 organic growth in Q3 came in at 5.2% for the group vs VA css at 6.7% and ODDO BHF at 6.3%. Nevertheless, the company confirms the guidance ...
>Neutral rating maintained with a higher target price of € 132 - Neutral rating maintained, with a higher target price of € 132. The half-day presentation of the group’s new strategy lends weight to our view that management will continue its focus on skin care and to expand the operating footprint. This should underpin investor confidence on the group’s level of resilience to generate EPS growth of 7-8% over the medium to long term. With a 2025e P/E of 30x which is cl...
>Neutre maintenu avec un OC relevé à 132 € - Neutre maintenu avec un OC relevé à 132 €. La demi-journée de présentation de la nouvelle stratégie du groupe nous conforte dans l’idée que le management va poursuivre sa focalisation sur le skincare et continuer d’étendre l’empreinte opérationnelle. Ceci devrait conforter la confiance des investisseurs sur le degré de résilience du groupe pour générer une croissance de BPA de 7% à 8% sur le moyen long terme. Avec un PE 25e...
Summary KOSE Corp - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights KOSE Corp (KOSE) manufactures and markets cosmetics and beauty products. The company’s products portfolio includes skincare products, moisturizers and toners, lipsticks, shampoos, hair conditioners, soaps, fa...
>Probable negative reaction despite this very good quarter - Neutral maintained with a target price raised to € 105 (from € 90) because of the adjustment of our DCF and the more sustainable long-term outlook in view of the continued organic growth recovery in the consumer division from one quarter to the next. At our target price, the implied 2024 PE is 26x (20x excluding cash), which seems reasonable to us amid the sliding valuation multiples of Food Beverage HPC sto...
>Probable réaction négative malgré ce très bon trimestre - Neutre maintenu avec un OC relevé à 105 € (vs 90 € ante) en raison du glissement de notre DCF et de perspectives de long terme plus soutenable au regard de la réitération du redressement de la croissance organique du Consumer qui se confirme trimestre après trimestre. A notre OC, le PE 24e ressort implicitement à 26x (20x hors cash), ce qui nous semble raisonnable dans ce contexte de ré-échelonnage vers les ba...
>Un S1 qui devrait être bien accueilli - Neutre maintenu (OC 90 €) compte tenu de la valorisation (PE 24e : 27x). La publication des résultats du S1 devrait être bien accueillie en raison d’un BPA 6% supérieur aux attentes et d’un relèvement de l’objectif de croissance organique du Consumer, désormais attendue en high single digit/low double digit. BPA du S1 à +17%, nettement au-dessus des attentes grâce à la très forte hausse de la MOP en Consumer - ...
>Interim results should be well received - Neutral recommendation maintained (TP € 90) given the valuation (PER 2024e: 27x). The publication of H1 results should be welcomed due to EPS that is 6% above expectations and an increase in the organic growth target of the Consumer division, now expected in high single digit / low double digit territory. H1 EPS at +17%, well ahead of expectations thanks to the very sharp rise in the operating margin for the Cons...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.